820dkk
-5,1 %
Date:2025-04-03Time:12:12:30Latest report:Q4-2024List:SpotlightTicker:CESSA
Market Cap:143 mdkkEnterprise Value:131 mdkkNet Sales:2,49 mdkkEarnings:-14,7 mdkkEmployees:0ISIN:DK0061411964

Ratios

10-year key figure history for Cessatech turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Cessatech with index and moving average MA50 and MA200.

Stockprice:8,20
MA50:10,33
MA200:11,21
Price/MA200:-26,8 %
RSI (14):32,5
Price/MA50:-20,6 %

Description

Cessatech’s business model offers unique, scalable economic value creation by identifying and developing drugs with a short time to market and risk-reduced profile. The drugs that are developed by Cessatech should be proven effective in adults and represent a medical unmet need in children where a focused development plan can be applied for documenting good effect in children.

Pharmaceuticals